Purpose
|
Vandetanib is an orally bioavailable 4-anilinoquinazoline. Vandetanib selectively inhibits the tyrosine kinase activity of vascular endothelial growth factor receptor 2 (VEGFR2), thereby blocking VEGF-stimulated endothelial cell proliferation and migration and reducing tumor vessel permeability. This agent also blocks the tyrosine kinase activity of epidermal growth factor receptor (EGFR), a receptor tyrosine kinase that mediates tumor cell proliferation and migration and angiogenesis.
|
Characteristics
|
Tradename: ZD6474 Source of Compound: synthetic Target: VEGFR antagonist, EGFR inhibitor Receptor: VEGFR2/EGFR
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
99?%
|
Formula
|
C22H24BrFN4O2
|
Solubility
|
DMSO 4 mg/mL,Water <1 mg="" ml="" <="" td="">
1> |